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Complete Freund's adjuvant produces a Syn-
drome of anemia and compensatory reticulocy-
tosis when injected into mice and guinea pigs
(1). This phenomenon is self limited, usually
lasting one to two weeks. It appears to be related
to increased phagocytic activity of the reticulo-
endothelial (RE) system induced by the myco-
bacterial and mineral oil components of the
adjuvant. The anemia and compensatory reticu-
locytosis seem to result from accelerated destruc-
tion of normal red blood cells by a hyperactive
spleen. Complete Freund's adjuvant also induces
formation and deposition of connective tissue in
the large sinuses surrounding the lymphoid nod-
ules in the spleen of the guinea pig. This reaction
has been called halo fibrosis. The connective
tissue appears to be composed of reticulum fibers
in a homogeneous appearing ground substance.
Lipid positive drops within macrophages are
found in the fibrous rings. Although the mech-
anism of production of halo fibrosis is not under-
stood, this phenomenon is dissociable from the
hematologic abnormalities. It can be produced
only by the complete adjuvant and not by its
individual components. If the latter, namely,
mycobacteria and mineral oil, are injected at
separate sites, fibrosis does not occur (1).
Zirconium and mycobacteria have the common
property of producing allergic granulomata in
man (2, 3, 4). Hence, it seemed worthwhile to
try to correlate the granuloma inducing capacity
of an agent with its ability to produce the hema-
tologic and connective tissue abnormalities noted
above. Zirconium as sodium zirconium lactate
was substituted for the mycobacteria in com-
plete adjuvant and tested for its ability to pro-
duce the above phenomena as well as to potenti-
ate formation of circulating antibodies and in-
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duction of delayed hypersensitivity to proteins.
The effect of sodium zirconium lactate itself upon
the RE system was also investigated in a pre-
liminary fashion.
It was hoped that these studies might lead to
a useful model for studying allergic granuloma
formation and immunologic adjuvant activity.
MATERIALS AND METHODS
Hartley strain guinea pigs of both sexes weigh-
ing 300—400 grams were purchased for these experi-
ments either from Tumblebrook Farms, Brant
Lake, New York, or Banta Farms, Hagaman,
New York. In the experiments on hematologic
and connective tissue abnormalities, the animals
were bled once or twice weekly from the retro-
orbital venous plexus with a capillary pipette.
No more than .025 ml of blood was obtained at
each bleeding and no more than .05 ml was ob-
tained each week. On this regimen none of the
animals became anemic, or developed an elevated
reticulocytosis. Previous experiments with com-
plete Freund's adjuvant showed that an elevated
reticulocyte count is an accurate indicator of the
bematologie disturbance (1). Therefore, only
retieuloeyte counts were done in the present ex-
periments except where noted. Osmotic fragility
studies and Coombs' tests for globulin adsorbed
onto red blood cells were performed on some
animals. Goat anti-guinea pig globulin (Micro-
biological Associates) was used for the Coombs'
tests as described in the previous paper. Tissues
for histologic examination were fixed in 10%
neutral formalin or Helley's solution, embedded
in paraffin, sectioned at 6M, and stained with a
variety of stains: hematoxylin and eosin, periodic
acid-Schiff (PAS). Van Gieson, Mallory triehrome,
Masson trichrome, Verhoeff stain for elastic tissue,
Laidlaw reticulum stain, colloidal iron, congo
red, crystal violet and phosphotungstic acid.
Frozen sections of various tissues were stained
with Putt's oil soluble Flaming Red for the detec-
tion of lipid (5). Tissues were examined by light
and phase microscopy as well as by dark field
and polarized light techniques.
Freund's complete adjuvant, incomplete ad-juvant, and killed Mycobacterium but yricuns
were obtained from Difco Laboratories and sodium
zirconium lactate solution from K and K labora-
tories. The zirconium solution was sterilized by
passage through a Millipore filter before use. It
was emulsified with incomplete adjuvant by re-
peated aspiration and ejection through an 18
gauge needle from a sterile syringe into a sterile
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ampoule. The animals were shaved and then
washed with pilisohex and 70% ethyl alcohol
prior to being injected with various materials.
The sodium zirconium lactate, lot number 11106
was a 50% aqueous solution containing approxi-
mately 13% zirconium measured as zirconium
oxide and the following impurities according to
the company assay:
Si02 .003% CuO .0003%
Fe203 .001% BaO .001%
MgO .001% Na20 2.45%
A120a .002% 1<20 .003%
Ca0
.001% Ti02 .0002%
Crystalline bovine serum albumin (BSA) was
obtained from Armour Pharmaceutical Co. and
egg albumin 5 times crystallized from Nutritional
Biochemicals Co.
The following experiments were carried out.
A) Three guinea pigs were injected subcutane-
ously with 0.5 ml of sodium zirconium lactate
solution. Microhematocrits and reticulocyte
counts were done at 3—7 days intervals
(Table I).
B) Twelve guinea pigs, divided into four equal
groups, were each injected with a total of
4 ml of the appropriate agent in four separate
subcutaneous sites. They were killed at the
end of 6 to 12 weeks and various organs were
examined histologically (Table II). Each
group received one of the following emul-
sions.
1) 2 ml of a dilution of sodium zirconium
lactate emulsified with 2 ml of incomplete
adj uvant
2) 2 ml of 3 dilution of sodium zirconium
lactate emulsified with 2 ml of incomplete
adjuvant3) 2 ml of ) dilution of sodium zirconium
lactate emulsified with 2 ml of incomplete
adjuvant
4) 2 ml of 0.9% saline emulsified with 2 ml
of incomplete adjuvant
All dilutions were made with 0.9% saline.
C) Fifteen guinea pigs were injected subcutane-
ously with 0.3 ml of sodium zirconium lactate
solution. Five of these animals received 10
mg of cortisone acetate and 5 received 25
mg of cortisone acetate suspension (Upjohn)
intramuscularly daily for two weeks at which
time the experiment was terminated.
Coombs' tests and osmotic fragility studies
were performed on ten of those animals
(Table III).
D) Fourteen animals were injected subcutane-
ously with 4 ml of an emulsion contnining
0.2 ml of sodium zirconium lactate and 1.8
ml of 0.9% saline emulsified with 2 ml of
incomplete adjuvnnt. The animals were
killed at 3, 6, 10, 13, 21, 28 and 42 days.
Tissues were examined with several stains
in order to observe changes leading to halo
fibrosis in the spleen.
E) Four animals received 0.2 ml of sodium
zirconium lactate subcutaneously at one
site and 2 ml of incomplete adjuvant at a
different site. They were killed 6 weeks later
and the tissues examined histologically.
F) Freund's adjuvant was fortified with Myco-
bacterium butyricum to raise the concentra-
tion of mycobacteria to 3 mg/ml. Thirty
mg of BSA in 1 ml of 0.9% saline were emulsi-
fied with 1 ml of this fortified complete
adjuvant. Two ml of this emulsion were
injected into each of 8 guinea pigs via foot
pad, intradermal and subcutaneous routes.
A second group of 9 guinea pigs was injected
in the same way with 30 mg of BSA in 1 ml
of saline emulsified with 1 ml of incomplete
adjuvant. A third group of 10 guinea pigs
was similarly immunized with the following
emulsion: 30 mg of BSA in 0.84 ml of 0.9%
saline and 0.16 ml of sodium zirconium
lactate emulsified with 1 ml of incomplete
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TABLE I
Hematologic changes produced in guinea pigs by the subcutaneous injection
of 0.5 ml of sodium zirconium lactate
Animal Number
Days after injection
0 7 9 it 10 24 29
1 Hot.
Retic.
48% 38%
1.0% 0.2%
35%
2.7%
31%
5.3%
41%
15.3%
46%
1.6%
46%
0.3%
2 Hat.
Ratic.
42%
1.5%
37%
2.0%
39%
7.3%
42%
5.7%
43%
8.1%
47%
2.0%
41%
0.9%
3 Ret.
Retic.
46%
2.0%
45%
1.5%
42%
6.0%
44%
12.0%
46%
7.0%
45%
3.0%
45%
1.5%
adjuvant. Animals ware bled prior to and
four weeks after immunization. Their sara
ware tested for hemagglutination titers to
BSA by the tanned cell method (6). (Fig. 1).
The concentration of BSA used in coating
the tanned cells was 1 mg/mI.
G) Freund's adjuvant was fortified with M.
butyricum to raise the concentration of
mycobacteria to 6 mg/mi. Twenty-four y
of BSA in 0.2 ml of 0.9% saline were emulsi-
fied with 0.2 ml of fortified complete ad-juvant. One tenth ml of this emulsion was
injected into each of the four foot pads of
18 guinea pigs. A second group of 12 guinea
pigs was immunized in identical fashion
using the following emulsion: 24T BSA in
0.2 ml of 0.9% saline were emulsified with
0.2 ml of incomplete adjuvant. A third group
of 15 guinea pigs was similarly immunized
with the following emulsion: 0.16 ml of
sodium zirconium lactate and 0.04 ml of
0.9% saline containing 24y BSA emulsified
with 0.2 ml of incomplete adjuvant. Five
days later the animals were tested intra-
dermally to by and bOy of BSA in 0.1 ml
of 0.9% saline as well as to first and second
strength PPD. Readings were made at 24,
48 and 72 hours (Table V).
H) Emulsions were prepared and administered
as in experiment C except that 40y of egg
albumin were substituted for the BSA.
Three groups of 6 guinea pigs each were used
in this experiment. Five days later the ani-
mals were skin tested intradermally with
0.1 ml of 0.9% saline containing lOy, SOy,
bOy and SOOy of egg albumin as well as
second strength PPD. Readings were made
at 24, 48 and 72 hours.
RESULTS
A. Hematologic Abnormalities
These preliminary studies indicated that so-
dium zirconium lactate by itself and as an emul-
TABLE II
Effect of increasing amounts of sodium zirconium
lactate in mineral oil upon the production of
hematologic and connective tissue abnormalities
in the guinea pig
Highest Nec-
Retic. Fb ropsy
count I rums (weeksj
sion with mineral oil behaved like complete
adjuvant in producing hematologic abnormalities
(Table I and II). There may be a detectable drop
in the hematocrit with compensatory reticulo-
cytosis, or the animal may compensate so quickly
and so well that no fall in hematocrit is detect-
able. Only the elevated reticulocyte count is
observed. The onset of hematologic abnormalities
was 7—14 days after injection and lasted one to
two weeks. This effect was similar to that noted
in the previous experiments with Freund's adju-
vant. Cortisone in 10 mg or 25 mg doses did
not prevent the destruction of red blood cells.
Coombs' tests were negative (Table III). Osmotic
fragility studies showed either no change or an
increased resistance to hypotonic solutions. The
Amount of zirconium
1 2 ml ko dii.
2 2 ml )j dii.
3 2 ml jj dii.
4 2ml)jdil.
5 2ml3dil.
6 2mlj-dil.
7 2mljdil.
8 2m1%dil.
9 2ml)-dil.
10 2 ml incomp. adj.
11 2 ml incomp. adj.
12 2 ml incomp. adj.
4.5%
4.6%
4.9%
7.5%
7.9%
7.6%
8.0%
8.8%
4.5%
2.0%
2.0%
1.6%
+
+
+
+
+
+
6
12
12
12
12
8
12
8
6
8
12
12
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TABLE III
Effect of cortisone acetote administered intra-
muscularly daily to guinea pigs injected
with 0.3 ml of sodium zirconium tact ate
Number
of
Animals
Cortisone
Dose Mean Retic. Count Coombs' Test
5 None 11.4 2.2% Negativa
5 10mg 9.0 3.6% Negative
5 25mg 9.6 2.5% —
The normal reticulocyte count in these guinea
pigs is 2.2 .95%, based upon counts done in 88
animals.
latter observation probably reflects the increased
resistance of reticuloeytes to disruption by hypo-
tonic solutions. Spherocytes were not seen in the
peripheral blood smears at the time of accelerated
red blood cell destruction. The animals did not
appear to be sick during the accelerated destruc-
tion of red blood cells. The data in Table TI sug-
gest that the hematologic and connective tissue
abnormalities are dose dependent and dissociable.
A reticulocyte count of 4.5% or higher was con-
sidered abnormal in these experiments.
B. Connective Tissue Abnormalities
Histologic examination of the spleens of ani-
mals given either zirconium or zirconium emul-
sified with incomplete adjuvant disclosed marked
RE cell proliferation, erythrophagocytosis and
extramedullary erythropoiesis. These tissue
changes were accompanied by an increase in the
weights of the spleens (Table IV). Zirconium
produced halo fibrosis only when emulsified with
incomplete adjuvant (Figs. 2—13). When zir-
conium and mineral oil were injected into sep-
TABLE TV
Weights of spleens after stimulation by sodium
zirconium lactate alone and as an emulsion
with incomplete adjuvant
Group Nner' Mean weight ot spleen
Animals (gm)
Control
Sodium zirconium lac-
tate (0.4 ml)
Sodium zirconium lac-
tate (0.2 ml in2ml of
incomplete adjuvant)
13
7
10
0.73 .14 gm
1.22 .40 gm
1.27 .37 gm
arate sites, fibrosis did not occur. Six weeks were
required for fibrosis to develop after zirconium
adjuvant was injected as opposed to four weeks
after injection of complete Freund's adjuvant.
Microscopic examination of spleens removed
from guinea pigs injected subcutaneously with
zirconium in incomplete adjuvant revealed RE
cell proliferation three days after injection;
extramedullary erythropoiesis within seven to
ten days; and lipid positive drops within macro-
phages in the red and white pulp after three to
four days. Large amounts of zirconium in the
skin or other organs appear as intracellular
granules that are PAS positive and stain reddish-
blue with hematoxylin and eosin. A few granules
seen in histiocytes in the spleen as early as six
days may have been zirconium. However, when
halo fibrosis developed, many cells containing
large numbers of typical zirconium granules were
present in the lymphoid nodules and fibrotic
rings. If guinea pigs are injected with sodium
zirconium lactate alone, and the spleens exam-
ined three months later, intracellular zirconium
granules are found primarily in areas other than
the lymphoid nodules and their immediately
surrounding sinuses. Halo fibrosis does not occur
under such circumstances.
This observation is similar to that seen in
guinea pigs injected with complete Freund's
adjuvant. Initially cells containing a few fat
positive droplets are seen diffusely throughout
the spleen. When halo fibrosis develops, calls
packed with fat positive material concentrate
almost exclusively in these halos.
The fibrotic halos appear homogeneous or
slightly fibrillar by light microscopy. Small
clusters of red blood cells and randomly dis-
tributed RE cells are scattered through this
fibrous ring, as if the connective tissue had been
laid down in a random manner entrapping the
constituents of the sinusoid. The halo does not
stain for amyloid or take the usual connective
tissue stains such as Van Gieson, Mallory tn-
chrome, colloidal iron and PAS. A silver stain
demonstrated many fine fibers with a homo-
geneous material between them. A meshwork of
fibers that did not polarize light was seen under
phase microscopy. Because of these findings, the
connective tissue was thought to be composed
of reticulum enmeshed in a homogeneous ground
substance. Future electron microscopic studies
will establish whether or not this inference is
correct.
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FIG. 2. Arrows indicate large sinus characteristically surrounding each lymphoid nodule in the nor-
mal guinea pig spleen. Hematoxylin and eosin X 140.
FIG. 3. High power view of sinus surrounding lymphoid nodule. Hematoxylin and eosin X 550.
FIG. 4. Typical appearance of helo fibrosis. Identical lesions are produced by complete Freund's
adjuvant and zirconium in water-in-oil emulsion. These fibrotic rings, present around most of the
lymphoid nodules, may remain discrete or fuse with neighboring rings. Hematoxylin and eoxin X 55.
FIG. 5. High power view of hub fibrosis. The lymphoid nodule is composed of mononuclear cells.
(cf. figures 7 and 8). Hematoxylin and eosin X 140.
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Fsa. 6. Higher power view of halo fibrosis. The ring appears more homogeneous than fibrillar. Clusters
of red blood cells and RE cells are scattered and entrapped in the halo. Hematoxylin and eosin x 550.
FIG. 7. Lymphoid nodule in which cells have been almost completely replaced by red blood cell
precursors. Note the widespread extramedullary erythropoiesis elsewhere in the spleen. This type of
lesion was seen in three animals who had marked reticuloeytosis. Halo fibrosis is also present. Hema-
toxylin and eosin X 55.
FIG. 8. High power view of figure 7. Erythropoiesis has almost completely replaced the normal con-
tents of the lymphoid nodule. Hematoxylin and eosin >< 140.
FIG. 9. High power view of figure 8. The halo appears more fibrillar than in figure 6. The arrow indi-
cates cells containing typical granules of zirconium. Hematoxylin and eosin X 550.
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FIG. 10. Lymphoid nodule containing many cells filled with typical granules of zirconium. These
cells appear in great numbers in the nodule when hub fibrosis begins to develop in the surrounding
sinus. Hematoxylin and eosin X 1400.
FIG. 11. High power view of halo shows PAS positive granules in cells. Note the homogeneous and
fibrillar aspects of this connective tissue. Periodic acid Sehiff X 1400.
FIG. 12. Section of hub fibrosis stained with silver discloses many fine argyrophilic fibers embedded
in a relatively homogeneous ground substance. Laidlaw reticulum stain X 1400.
FIG. 13. Same field as figure 12, but viewed with phase microscopy. Note the dense fibrous meshwork
that has become evident. Laidlaw reticulum stain )< 1400.
515
tf
a 'pr
4
'1%
Si
A
7*
516 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Three guinea pigs that developed a high reticu-
loeyte count after injection with zirconium in
incomplete adjuvant showed a striking splenic
lesion which was identical to that seen previously
in guinea pigs with severe nnemia and high
reticulocytc count following treatment with com-
plete adjuvant. The lymphoid nodules were al-
most completely devoid of mononuclear cells
with the entire structure being replaced by
erythropoietic elements. The rest of the spleen
was also completely crythropoietic.
C. Immunologic Studies
Figure 1 shows that only complete Freund's
adjuvant potentiated the formation of antibodies
to BSA. The zirconium emulsion did not act as
an immunologic adjuvant. Table V shows the
results of delayed hypersensitivity skin reactions
to BSA which is normally a weak antigen in the
guinea pig. Not only were there more positive
skin reactions in the group immunized with BSA
in complete adjuvant but these reactions showed
more erythema and induration than in the groups
immunized with BSA in incomplete adjuvant.
These skin tests also persisted 24 hours longer
than those in the other two groups, that is 72
hours versus 48 hdurs.
Egg albumin is a strong antigen in the guinea
pig. Ta this series of experiments all the animals
showed strongly positive skin tests. However, the
skin tests in animals immunized with egg albumin
in complete adjuvant showed more induration
and erythcma and persisted 24 to 48 hours longer
than those done in animals immunized with egg
albumin in the incomplete and zirconium adju-
vants.
From the data in Table V and Figure 1 there
is a suggestion that the zirconium actually might
TABLE V
Delayed hypersensitivity reactions to bovine serum
albumin produced in guinea pigs with complete,
incomplete and zirconium adjuv ants
Group
Number of
positive skin
tests
Size of
lesion in
millimetees
BSA in complete Freund's 15/18
adjuvant
BSA in incomplete adjuvant 6/12
BSA in zirconium adjuvant 4/15
3—S
3—6
3—5
inhibit formation of humoral antibodies and in-
duction of delayed hypersensitivity to BSA.
Further studies along these lines are in progress.
DIscUssION
These experiments suggest that there is an
accelerated destruction of normal red blood cells
and that it may be caused by increased phago-
cytic activity of the RE system. The observed
blood abnormalities are similar to those seen in
guinea pigs and mice treated with complete
adjuvant, estradiol, Thorotrast (1) and zymosan
(7). With these four agents it does appear that
increased phagocytosis by the RE system is
responsible for the drop in hcmatocrit and com-
pensatory rcticulocytosis.
The absence of spherocytosis, negative Coombs'
tests, inability of 10 mg and 25 mg of cortisone
acetate to prevent these abnormalities and the
normal or decreased fragility to hypotonic solu-
tions are arguments for the role of non-immuno-
logic factors in the production of the anemia and
com.pensatory reticulocytosis. The above four
factors characterize the anemia-reticulocytosis
phenomena observed in guinea pigs treated with
zirconium and complete Freund's adjuvant and
support a common pathogenesis of these phe-
nomena in the two groups of animals.
Sodium zirconium lactate is a complex salt
which behaves as a colloid (8, 9). It selectively
localizes in the RE system of the spleen, liver
and bone marrow. This unique property of zir-
conyl complex salts has lcd to their being used
in the treatment of chronic lcukcmias and lym-
phomas (10). Zirconium is combined with radio-
active phosphate to form zirconyl phosphate
which localizes in and selectively irradiates liver,
spleen and bone marrow.
In the present experiments, PAS positive zir-
conium granules were found in liver, spleen and
lymph nodes. The weights of the splceas were
increased (Table IV), and hyperplasia of the RE
system was seen microscopically. Marked eryth-
rophagocytcsis, hemosiderin deposits, and extra-
medullary crythropoiesis were also observed in
the splecns.
These data arc compatible with the thesis that
an accelerated destruction of red blood cells
caused by an overly phagocytic RE system was
operative in these experiments. Carbon clearance
and red cell survival studies will establish whether
PPD second strength—size of lesion—S--13 mm. this thesis is correct. The preseat experiments
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as well as the previous ones with zymosan,
Thorotrast, estradiol and complete adjuvant,
do not rule out the possibility that the red blood
cell is somehow damaged by these agents so that
a corpuscular defect contributes to its accelerated
destruction.
Formation and deposition of connective tissue
in the sinuses of the spleen have been associated
only with injections of zirconium or mycobacteria
combined with mineral oil. Lipid positive drops
and zirconium granules were always found in the
fibrotic rings. The oil had to be combined with
zirconium or myeobaeteria as an emulsion or
suspension and injected as a unit. If the constitu-
ent parts were injected separately, fibrosis did
not occur. Other substances have been emulsified
with mineral oil and injected into guinea pigs
without producing these connective tissue ab-
normalities. Substances tried include: penicillin,
sulfonamides, Mesantoin, streptomyein, neo-
myein, benzoeaine, dextran and bovine serum
albumin (1).
The mechanism of formation of halo fibrosis is
not known except that the constituents of com-
plete Freund's adjuvant or zirconium adjuvant
must be injected together in one site. Kabat
(11) showed that allergic eneephalomyelitis in the
monkey may be prevented by injecting myeo-
bacteria in one site and the brain tissue emulsion
in mineral oil at another site. He postulated that
the myeobaeteria in the adjuvant functioned to
bring about the formation of epithelioid cells in
the presence of brain tissue. Theoretically, this
event starts the chain of reactions leading to the
production of this immunologic disease.
Perhaps an analogous situation exists in the
formation of halo fibrosis by complete and zir-
conium adjuvants. The mineral oil might in-
fluence the RE system locally to react with the
zirconium or myeobaeteria in such a way that
when these materials reached the spleen in proper
concentration, fibrotic rings are formed. This
interaction need not necessarily be an immuno-
logic one. It is also possible that the zirconium
and myeobaeteria might influence the RE system
to respond differently to the presence of the
mineral oil so that when this substance arrived
in the spleen in the proper concentration halo
fibrosis would result. It was shown in previous
experiments that these fibrotic rings were found
in only one out of 35 guinea pigs injected within-
complete adjuvant (1). Almost all the guinea pigs
receiving complete adjuvant developed halos.
Regardless of what the mechanism proves to be,
it is clear that zirconium and myeobaeteria sig-
nificantly influence the effect of mineral oil upon
the RE system.
Zirconium possessed no immunologic activity
in terms of its ability to potentiate the formation
of circulating antibodies or delayed hypersensi-
tivity to BSA. Similar studies were performed to
test the action of beryllium as an immunologic ad-
juvant (12). Beryllium adjuvants similar to the
zirconium adjuvants used in these experiments
did not potentiate antibody formation or delayed
hypersensitivity to BSA. The authors suggested
that their results indicated a possible difference in
the nature of the granuloma produced by the
myeobaeteria and beryllium. The immunologic
adjuvant potential of a substance need not be as-
sociated with granuloma forming ability. How-
ever, could there be a correlation between halo
fibrosis production and granuloma formation?
Such an association might prove useful in investi-
gating allergic granuloma formation. This aspect
of the problem is currently being pursued using
beryllium and colloidal silica incorporated into
mineral oil.
The phenomenon of halo fibrosis is interesting
in another respect. The connective tissue is ap-
parently formed and deposited in the sinuses sur-
rounding the lymphoid nodule without any pre-
ceding necrotic, inflammatory, or granulomatous
reaction. It is analogous to the situation in selero-
derma in which the abnormal connective tissue
changes occur without any known preceding in-
flammatory reaction. The connective tissue in this
fibrotic halo appears to be composed of a mesh-
work of reticulum fibers embedded in a homo-
geneous ground substance. This may prove to be a
useful model for the study of the selerodermatous
process.
sUMMARY
1. Sodium zirconium lactate acts as a eolloid
and appears to stimulate the RE system with a
resultant accelerated destruction of normal red
blood cells.
2. The anemia and compensatory retieuloeyto-
sis seen in guinea pigs treated with sodium zir-
conium lactate is associated with a negative
Coombs' test, absence of spheroeytosis, normal or
decreased fragility to hypotonie solutions, and is
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not prevented by immunosuppressive doses of
cortisone acetate.
3. Connective tissue is produced and deposited
in the sinuses surrounding the lymphoid nodules
of the spleen by injections of sodium zirconium
lactate in mineral oil. These changes are identical
to those seen in animals treated with complete
Freund's adjuvant.
4. Sodium zirconium lactate does not act as an
immunologic adjuvant. It does not potentiate the
formation of humoral antibodies or delayed hy-
persensitivity to bovine serum albumin.
5. A suggestion is made that there may be a
correlation between the induction of helo fibrosis
in the spleen and the granuloma forming ability
of a particular substance.
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